AI-generated summary
The authors randomly assigned patients with temporomandibular joint pain to active helium-neon laser therapy or sham laser therapy over eight weeks and measured pain during function. Both groups improved within themselves, but differences between the active and sham groups were not evident. The authors conclude that low-level laser therapy was not better than placebo for reducing this pain.
- Who or what was studied
- Patients with temporomandibular joint pain
- Limits stated in the abstract
- The abstract does not describe the study's sample size calculation, follow-up beyond eight weeks, or any limits beyond the sham comparison design.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 30 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.